We help patients to benefit from the scientific discoveries
The purpose of our work is to help people understand genetic background of the tumor and use this information to fight their cancer.
believe know that CLINICALLY VALUABLE INFORMATION FROM TUMOR GENOME IS WAITING TO BE DISCOVERED
By combining cutting-edge genome analysis with latest technological breakthroughs in AI we develop analytical tools delivering key answers to patients and clinicians.
Meet our team!
Our interdisciplinary team combines expertise in DNA chemistry and cell biology, with AI and machine learning to provide cutting-edge genome analysis and develop new approaches to personalized medicine. We work together toward a common vision. This interdisciplinary environment allows us to achieve the impossible.
After returning to Poland in 2017, together with a group of enthusiastic specialists/scientists, she founded the company MNM Diagnostics, where she conducts research and analyses on personalized diagnostics and the selection of anti-cancer targeted therapies.
He initially gained experience in companies such as eSmoking Institute, eSmoking Liquids, CHIC and BAT. His main responsibilities included Quality Management System Implementation (ISO 9001 and 17 025), Quality Assurance, R&D, Product Safety and Compliance and Import.
A former member of Technical Committee and Working Groups of CEN (European Committee for Standardization) and PKN (Polish Committee for Standardization) in the area of alternative tobacco products.
At MNM Diagnostics, he is responsible for the creation, development and management of the Commercial part of business (including commercial strategy co-creation).
Privately a beekeeper and enthusiast of street theatre.
Scientific advisory board
Kelly Gordon, PhD
Walter Carney, PhD
Frances Toneguzzo, PhD
Want to join us? See current job offers!